Replicel Life Sciences Inc V.RP

Alternate Symbol(s): REPCF

Healthcare Biotechnology

RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair restoration. RCH-01 is an autologous cell therapy utilizing dermal sheath cup (DSC) cells isolated from the hair follicle to treat androgenetic alopecia. RCS-01 is an autologous cell therapy utilizing non-bulbar dermal sheath (NBDS) cells, a type of fibroblast cell isolated from the hair follicle to repair and regenerate tissue. RCT-01 provides a source of collagen expressing cells to the site of injury, addressing the underlying cause of tendinosis. It has also developed an injection device, DermaPrecise, which improves the administration of its cell therapy products and certain other injectables.

TSXV:RP - Post by User

Replicel Life Sciences Inc > Last Minute Trading

<< Previous

Bullboard Posts

Next >>

Comment by Ingiboyon Feb 11, 2021 10:33pm

101 Views

Post# 32549010

RE:RE:RE:RE:Last Minute Trading

I would love to play some mind games with these a-holes and do just that but I am loaded with shares. You are right it is someone or a fund from Raymond James.
I wish some of the big shareholders with deep pockets would put an end to this.
1,000 shares take the entire pool of shares 33,000,000+ down 5%....total BS.

<< Previous

Bullboard Posts

Next >>

Invest wiser with BMO's InvestorLine Platform features